Abstract
Electrocardiogram (ECG) signals play a pivotal role in cardiovascular diagnostics, providing essential information on the electrical activity of the heart. However, the inherent noise and limited resolution in ECG recordings can hinder accurate interpretation and diagnosis. In this paper, we propose a novel model for ECG super resolution (SR) that uses a DNAE to enhance temporal and frequency information inside ECG signals. Our approach addresses the limitations of traditional ECG signal processing techniques. Our model takes in input 5-second length ECG windows sampled at 50 Hz (very low resolution) and it is able to reconstruct a denoised super-resolution signal with an x10 upsampling rate (sampled at 500 Hz). We trained the proposed DCAE-SR on public available myocardial infraction ECG signals. Our method demonstrates superior performance in reconstructing high-resolution ECG signals from very low-resolution signals with a sampling rate of 50 Hz. We compared our results with the current deep-learning literature approaches for ECG super-resolution and some non-deep learning reproducible methods that can perform both super-resolution and de-noising. We obtained current state-of-the-art performances in super-resolution of very low resolution ECG signals frequently corrupted by ECG artifacts. We were able to obtain a signal-to-noise ratio of 12.20 dB (outperforms previous 4.68 dB), mean squared error of 0.0044 (outperforms previous 0.0154) and root mean squared error of 4.86% (outperforms previous 12.40%). In conclusion, our DCAE-SR model offers a robust (to artefact presence), versatile and explainable solution to enhance the quality of ECG signals. This advancement holds promise in advancing the field of cardiovascular diagnostics, paving the way for improved patient care and high-quality clinical decisions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Next Generation EU
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data are available at: \url{https://physionet.org/content/ptb-xl/1.0.3/}.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
